Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Immune system and Cisplatin, with related work in DU145, Fibrinogen, Ectopic expression. Notable publications include 'The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma', 'Silencing long non-coding RNA NEAT1 enhances the suppression of cell growth, invasion, and apoptosis of bladder cancer cells under cisplatin chemotherapy', and 'YAP knockdown inhibits proliferation and induces apoptosis of human prostate cancer DU145 cells'.
Lipid Visualization of 3D-hetero-type Multicellular Spheroids During the Spatiotemporal Progression of Pancreatic Cancer
MicroRNA-217 aggravates breast cancer through activation of NF1-mediated HSF1/ATG7 axis and c-Jun/ATF3/MMP13 axis
The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma
[Abnormal expression of CD44 aggravates liver disease progression in patients with non-alcoholic fatty liver disease accompanied with hepatitis B virus replication].
High Fibrinogen and Platelets Correlate with Poor Survival in Gastric Cancer Patients.
PubMed 2020cited by 18position: middle
Silencing long non-coding RNA NEAT1 enhances the suppression of cell growth, invasion, and apoptosis of bladder cancer cells under cisplatin chemotherapy.
PubMed 2019cited by 21position: middle
YAP knockdown inhibits proliferation and induces apoptosis of human prostate cancer DU145 cells
The Role of MDM4 SNP34091 A>C Polymorphism in Cancer: A Meta-Analysis on 19,328 Patients and 51,058 Controls